Search
Patexia Research
Case number 1:21-cv-01553

Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al > Summary

Court Case Number 1:21-cv-01553

Filing Date Oct 29, 2021

Court Delaware District Court

Status Unknown

JudgesMaryellen Noreika

Defendant Attorneys

22

Zydus Pharmaceuticals
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Worldwide
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Zydus Worldwide
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Lifesciences Limited
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Zydus Lifesciences Limited
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Pharmaceuticals
Attorney Name: Leah M. Brackensick
Locke Lord

Zydus Pharmaceuticals
Attorney Name: Jennifer M. Coronel
Locke Lord

Zydus Pharmaceuticals
Attorney Name: Michael J. Gaertner
Locke Lord

Zydus Pharmaceuticals
Attorney Name: Timothy F. Peterson
Locke Lord

Zydus Worldwide
Attorney Name: Timothy F. Peterson
Locke Lord

Zydus Lifesciences Limited
Attorney Name: Timothy F. Peterson
Locke Lord

Zydus Lifesciences Limited
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Pharmaceuticals
Attorney Name: Jennifer M. Coronel

Zydus Pharmaceuticals
Attorney Name: Leah M. Brackensick

Zydus Pharmaceuticals
Attorney Name: Michael J. Gaertner

Zydus Pharmaceuticals
Attorney Name: Timothy F. Peterson

Zydus Lifesciences Limited
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Pharmaceuticals
Attorney Name: Timothy F. Peterson

Zydus Lifesciences Limited
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Lifesciences Limited
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Zydus Pharmaceuticals
Attorney Name: Timothy F. Peterson

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
11040029 Methods for the administration of certain VMAT2 inhibitors Jun 22, 2021
11026931 Methods for the administration of certain VMAT2 inhibitors Jun 8, 2021
11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto Jun 8, 2021
10993941 Methods for the administration of certain VMAT2 inhibitors May 4, 2021
10952997 Methods for the administration of certain VMAT2 inhibitors Mar 23, 2021
10940141 Methods for the administration of certain VMAT2 inhibitors Mar 9, 2021
10919892 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 16, 2021
10912771 Methods for the administration of certain VMAT2 inhibitors Feb 9, 2021
10906902 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
10906903 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
10874648 Methods for the administration of certain VMAT2 inhibitors Dec 29, 2020
10857137 Methods for the administration of certain VMAT2 inhibitors Dec 8, 2020
10857148 Methods for the administration of certain VMAT2 inhibitors Dec 8, 2020
10851103 Valbenazine salts and polymorphs thereof Dec 1, 2020
10851104 Valbenazine salts and polymorphs thereof Dec 1, 2020
10844058 Valbenazine salts and polymorphs thereof Nov 24, 2020
10065952 Valbenazine salts and polymorphs thereof Sep 4, 2018
Menu